In a separate study, Lan CC et al. examined the prognostic value of hematologic inflammatory biomarkers, specifically the neutrophil-percentage-to-albumin ratio (NPAR), NLR, and ELR, in predicting COPD mortality. This evidence concerns the gene ALB and chronic obstructive pulmonary disease.